A. Maarek

Impact of a Visual Support Dedicated to Prognosis on Symptoms of Stress of ICU Family Members: A Before-and-After Implementation Study

Gabrielle Veislinger-Burelli, Arthur Vincent, Jeremy Mallard, 2021, Critical care explorations.

Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis

A. Maarek, A. Moktefi, T. Damy, 2022, EJHaem.

HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma

A. Maarek, E. Ferrant, L. Karlin, 2022, Blood advances.

Molecular analysis of a CD19-negative diffuse large B-cell lymphoma

A. Plesa, S. Hayette, A. Maarek, 2018, Haematologica.

Characteristics of T- and NK-cell Lymphomas After Renal Transplantation: A French National Multicentric Cohort Study

P. Gaulard, G. Salles, P. Rieu, 2021, Transplantation.

Evaluation of Participation and Recruitment Bias in a Prospective Real-Life Multicentric Cohort « Real World Data in Lymphoma and Survival in Adults » (REALYSA study) for Newly Diagnosed Lymphoma Patients over One Year in a Hematology Department of Teaching Hospital

A. Maarek, C. Le Lan, F. Bouafia, 2022, Blood.

Venetoclax induces profound and sustained responses in patients with relapsed/refractory light‐chain amyloidosis

F. Lemonnier, C. Haioun, A. Maarek, 2021, British journal of haematology.

Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment

F. Lemonnier, C. Haioun, A. Maarek, 2020, Leukemia & lymphoma.

Venetoclax induces sustained complete responses in refractory/relapsed patients with cardiac AL amyloidosis.

F. Lemonnier, C. Haioun, A. Maarek, 2019, Journal of Clinical Oncology.